Concepedia

Publication | Open Access

Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma

55

Citations

22

References

2023

Year

Abstract

ClinicalTrials.gov Identifier: NCT03077828.

References

YearCitations

Page 1